Apellis Pharmaceuticals, Inc. financial data

Symbol
APLS on Nasdaq
Location
Waltham, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 30 Oct 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 387% % -2.7%
Quick Ratio 48% % -32%
Debt-to-equity 276% % 7.8%
Return On Equity 19% %
Return On Assets 5% %
Operating Margin 8% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 126,525,218 shares 1.7%
Common Stock, Shares, Outstanding 126,500,000 shares 3.6%
Entity Public Float $4,200,000,000 USD -61%
Common Stock, Value, Issued $12,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 126,424,000 shares 1.8%
Weighted Average Number of Shares Outstanding, Diluted 130,067,000 shares 4.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $1,016,396,000 USD 42%
Research and Development Expense $297,974,000 USD -7%
Operating Income (Loss) $80,403,000 USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $46,681,000 USD
Income Tax Expense (Benefit) $1,695,000 USD -26%
Net Income (Loss) Attributable to Parent $44,986,000 USD
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $479,171,000 USD 21%
Accounts Receivable, after Allowance for Credit Loss, Current $345,538,000 USD 24%
Inventory, Net $122,819,000 USD 1.5%
Other Assets, Current $10,158,000 USD -14%
Assets, Current $990,676,000 USD 19%
Property, Plant and Equipment, Net $1,927,000 USD -43%
Operating Lease, Right-of-Use Asset $19,720,000 USD 16%
Other Assets, Noncurrent $5,491,000 USD 279%
Assets $1,058,723,000 USD 17%
Accounts Payable, Current $38,602,000 USD -9.7%
Accrued Liabilities, Current $140,322,000 USD 0.35%
Liabilities, Current $279,527,000 USD 46%
Operating Lease, Liability, Noncurrent $13,680,000 USD 20%
Other Liabilities, Noncurrent $3,257,000 USD -67%
Liabilities $657,555,000 USD -1.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax $2,400,000 USD 24%
Retained Earnings (Accumulated Deficit) $2,954,027,000 USD 1.5%
Stockholders' Equity Attributable to Parent $401,168,000 USD 69%
Liabilities and Equity $1,058,723,000 USD 17%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $53,410,000 USD 60%
Net Cash Provided by (Used in) Financing Activities $108,212,000 USD -72%
Net Cash Provided by (Used in) Investing Activities $8,000 USD 97%
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 126,500,000 shares 3.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $52,785,000 USD -109%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $480,601,000 USD 21%
Interest Paid, Excluding Capitalized Interest, Operating Activities $11,092,000 USD 575%
Deferred Tax Assets, Valuation Allowance $723,583,000 USD -4%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross $726,404,000 USD -3.9%
Operating Lease, Liability $16,954,000 USD -5.3%
Depreciation $446,000 USD 0.45%
Payments to Acquire Property, Plant, and Equipment $8,000 USD -97%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $45,726,000 USD
Lessee, Operating Lease, Liability, to be Paid $18,307,000 USD -7.5%
Operating Lease, Liability, Current $7,022,000 USD 3.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two $7,076,000 USD 13%
Lessee, Operating Lease, Liability, to be Paid, Year One $7,468,000 USD 1%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure -14%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1,353,000 USD -29%
Lessee, Operating Lease, Liability, to be Paid, Year Three $2,351,000 USD -56%
Deferred Tax Assets, Operating Loss Carryforwards $312,672,000 USD -5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $559,000 USD -35%
Operating Lease, Payments $2,311,000 USD 14%
Additional Paid in Capital $3,357,583,000 USD 3.7%
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%